EBASTINE Oral orodispersible tablet Ref.[8262] Active ingredients: Ebastine

Publisher: QualitecFarma, S.L., Ochandiano 10, Ed. 10, 28023 – Madrid, Spain

Therapeutic indications

Ebastine 10 mg orodispersible tablet is indicated for the symptomatic treatment of:

  • Allergic rhinitis (seasonal and perennial) whether or not associated with allergic conjunctivitis.
  • Idiopathic chronic urticaria.
  • Allergic dermatitis.

Posology and method of administration

Posology

Adults and children 12 years old and over

The usual dose is one orodipsersible tablet (10 mg of ebastine) once a day.

Children less than 12 years old

The administration of this pharmaceutical form is not recommended in children less than 12 years old.

Elderly patients

No dose adjustment is needed.

Renal impairment

No dose adjustment is needed in patients with mild, moderate or severe renal insufficiency.

Hepatic impairment

No dose adjustment is needed in patients with mild or severe hepatic insufficiency. A dosage of 10 mg should not be exceeded in patients with severe hepatic insufficiency, since no clinical studies have been developed with a higher dose than 10 mg.

Method of administration

Oral route.

Ebastine orodispersible tablets can be taken with or without food.

The dose of ebastine orodispersible tablet is placed on the tongue, where it disperses instantly. Water or other liquid is not needed to swallow the dose.

Immediately before use, the blister must be carefully peeled open with dry hands and the dose of orodispersible tablet removed without crushing it. The dose must be taken as soon as the blister has been opened.

Duration of use

Treatment may be prolonged until symptoms disappear.

Overdose

In studies conducted at a high dosage, no clinically meaningful signs or symptoms were observed up to 100 mg given once-daily. There is no specific antidote for ebastine. Gastric lavage, monitoring of vital functions including ECG and symptomatic treatment should be carried out.

Shelf life

18 months.

Special precautions for storage

No special precautions for storage.

Nature and contents of container

Aluminium/PA/PVC-Aluminium blisters containing 10, 20, 30, 50 or 100 orodispersible tablets.

Not all pack sizes may be marketed.

Special precautions for disposal and other handling

No special requirements for disposal.

Any unused product or waste material should be disposed of in accordance with local requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.